MedPath

ALECENSA Drug Use Surveillance

Not Applicable
Conditions
ung Cancer
Registration Number
JPRN-UMIN000014989
Lead Sponsor
Chugai Pharmaceutical Co. Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
1000
Inclusion Criteria

Not provided

Exclusion Criteria

No criteria

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety; ADR occurrence
Secondary Outcome Measures
NameTimeMethod
Efficacy; Tabulation of patient outcomes (survival/death), calculation of one-year survival rate
© Copyright 2025. All Rights Reserved by MedPath